Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03287557 · ClinicalTrials.gov registry record
Dysregulated CNS Inflammation After Acute Brain Injury
A clinical trial, sponsored by University of Kentucky.
- Completed
- Registry status
- 8
- Enrollment target
NCT03287557: Completed study, sponsored by University of Kentucky.
NCT03287557 is a clinical trial that has completed, run by University of Kentucky. The registered enrollment target is 8 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03287557 has completed, sponsored by University of Kentucky.
- COMPLETED
- Registry status
- 8 participants
- Enrollment target
Study Summary
By doing this study, the investigator hopes to learn how the levels of important proteins involved in inflammation change over time in patients with acute brain injury. The total amount of time participants will be asked to volunteer for this study is approximately two hours over a five day period.
Primary Outcome
CSF collection
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2018-01-02 |
| Est. Completion | 2019-05-24 |
What the finished NCT03287557 record still lists
NCT03287557 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 8 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT03287557 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03287557 about?
NCT03287557 is a clinical study titled "Dysregulated CNS Inflammation After Acute Brain Injury". By doing this study, the investigator hopes to learn how the levels of important proteins involved in inflammation change over time in patients with acute brain injury. The total amount of time participants will be asked to volunteer for this study is approximately two hours over a five day period.
What is the current status of trial NCT03287557?
This trial is currently completed. The enrollment target is 8 participants. The study started on 2018-01-02. Estimated completion is 2019-05-24.
Who is sponsoring clinical trial NCT03287557?
This trial is sponsored by University of Kentucky, which has 54 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI